NewsBenzinga뱅크오브아메리카 증권, 아덴트 헬스에 대한 투자의견 ‘시장수익률 하회’ 유지, 목표주가 14달러로 상향 뱅크오브아메리카 증권, 아덴트 헬스에 대한 투자의견 ‘시장수익률 하회’ 유지, 목표주가 14달러로 상향 Benzinga 2026.11.13 13:44 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 Ex-Carlyle Executive Launches Asia Secondaries Firm as $3 Trillion Sits Locked in Private Funds 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report